Bisphosphonates and the upper gastrointestinal tract: Skeletal gain without visceral pain?

Mayo Clinic Proceedings

Volumn 77, Issue 10, 2002, Pages 1029-1030

  Tremaine, William J ^a   Khosla, Sundeep ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; COLON CANCER; DEEP VEIN THROMBOSIS; DRUG INDUCED DISEASE; DRUG SAFETY; EDITORIAL; ESOPHAGITIS; ESTROGEN THERAPY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL TOXICITY; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

EID: 0036787415     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.10.1029     Document Type: Editorial

References (10)

1. de Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335:1016-1021.
2. Fosamax (alendronate sodium tablets) [package insert]. West Point, Pa: Merck & Co, Inc; 1996.
3. Cryer B, Bauer DC. Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence? Mayo Clin Proc. 2002;77:1031-1043.
4. Greenspan S, Field-Munves E, Tonino R, et al. Tolerability of once-weekly alendronate in patients with osteoporosis: a randomized, double-blind, placebo-controlled study. Mayo Clin Proc. 2002;77:1044-1052.
5. Melton LJ III. Who has osteoporosis? a conflict between clinical and public health perspectives. J Bone Miner Res. 2000;15:2309-2314.
6. Feuer EJ, Wun LM. DEVCAN: Probability of Developing or Dying of Cancer [Computer program]. Version 4.1. Bethesda, Md: National Cancer Institute; 1999.
7. Melton LJ III, Cooper C. Magnitude and impact of osteoporosis and fractures. In: Marcus R, Feldman D, Kelsey I, eds. Osteoporosis. Vol 1. 2nd ed. San Diego, Calif: Academic Press; 2001:557-567.
8. Marquez MA, Melton LJ III, Muhs JM, et al. Bone density in an immigrant population from Southeast Asia. Osteoporos Int. 2001;12:595-604.
9. Melton LJ III, Marquez MA, Achenbach SJ, et al. Variations in bone density among persons of African heritage. Osteoporos Int. 2002;13:551-559.
10. Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.